Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis
There is a scarcity of data exploring the benefits of adjuvant or neoadjuvant chemotherapy in the treatment of breast cancer in older women. We used data from the National Cancer Database, a joint project of the Commission on Cancer and the American College of Surgeons. Between Jan 1, 2004, and Dec 31, 2014, 16 062 women with triple-negative breast cancer in the database met the inclusion criteria.
